Details for New Drug Application (NDA): 204654
✉ Email this page to a colleague
The generic ingredient in LO MINASTRIN FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 204654
Tradename: | LO MINASTRIN FE |
Applicant: | Apil |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 1 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE, TABLET;ORAL | Strength | 0.01MG,0.01MG,N/A;1MG,N/A,N/A | ||||
Approval Date: | Jul 24, 2013 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 2, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | PREVENTION OF PREGNANCY |
Expired US Patents for NDA 204654
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Apil | LO MINASTRIN FE | ethinyl estradiol; norethindrone acetate | TABLET, CHEWABLE, TABLET;ORAL | 204654-001 | Jul 24, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Apil | LO MINASTRIN FE | ethinyl estradiol; norethindrone acetate | TABLET, CHEWABLE, TABLET;ORAL | 204654-001 | Jul 24, 2013 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription